Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (108)

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease

    Frontiers in Immunology, Vol. 14

  3. Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus

    Frontiers in Immunology, Vol. 14

  4. Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus (Front. Immunol., (2023), 14, (1235053), 10.3389/fimmu.2023.1235053)

    Frontiers in Immunology

  5. Editorial: Modulation of human immune parameters by anticancer therapies, volume II

    Frontiers in Immunology

  6. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

  7. Immunopathology of multiple sclerosis

    Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (Elsevier), pp. 11-26

  8. Inherited human ezrin deficiency impairs adaptive immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 997-1009.e11

  9. Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression

    Biomedicines, Vol. 11, Núm. 4

  10. Myeloid-derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure: Increased levels of MDSCs in recurrent reproductive failure

    American Journal of Reproductive Immunology, Vol. 90, Núm. 5

  11. Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients

    Frontiers in Immunology, Vol. 14

  12. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

  13. Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy

    Biomedicines, Vol. 11, Núm. 9

  14. The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022)

    Frontiers in Immunology, Vol. 14